Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View

Moderna, Inc. (MRNA) reported earnings of 55 cents per share in the fourth quarter of 2023, beating the Zacks Consensus Estimate of a loss of 78 cents. Earnings declined 85% in the quarter. The year-over-year decline in the bottom line was due to lower product sales during the quarter.Revenues in the quarter were $2.81 billion, beating the Zacks Consensus Estimate of $2.55 billion. Total revenues declined 45% year over year due to lower COVID-19 vaccine sales during the quarter.Moderna’s shares were up 6.1% ...